Delivery Order SPE2DB22D1017-SPE2DB25FF3XU

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,761.36 Firm Fixed Price contract is for the delivery of JANUMET 50-1,000 MG TABLET 60S, a pharmaceutical product, with a completion date of November 22, 2023. This award is a Delivery Order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $11,190.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a performance period through January 13, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of JANUMET 50-1,000 MG TABLET 60S. The $3,516.17 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.71 firm fixed-price delivery order is for 4564743324 JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $11,715.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with an ultimate completion date of October 20, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $11,387.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JANUMET 50-1,000 MG TABLET 180S, with an ultimate completion date of November 30, 2023. The award is not associated with any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $10,883.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, covers the procurement of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, for a period ending on December 18, 2023. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds...
This federal contract award, valued at $3,866.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of JANUMET 50-1,000 MG TABLET 180S, a diabetes medication, to support military healthcare programs. The contract has an ultimate completion date of July 26, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $4,562.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566872473 JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of January 9, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, and there is no set-aside designation mentioned. AmerisourceBergen holds a...
This federal contract award, valued at $7,880.29, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of November 29, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3XU
    Delivery Order

This federal contract award, valued at $1,086.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. It is a firm fixed-price Delivery Order, with an ultimate completion date of January 27, 2025.

The contract award is not designated as a set-aside and is open to full and open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

In addition to this specific contract award, AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/25/25, 10:13 AM